Comprehend Clinical Releases New Clinical Reporting and Visualization Software
Comprehend Systems, Inc., the makers of Comprehend Clinical, will be offering live demonstrations of the new version of their software at the Drug Information Association's 47th Annual Meeting, DIA 2011, to be held in Chicago on June 19-23, 2011. Comprehend Clinical is a next-generation web-based reporting and visualization platform which makes it easier to understand, explore, and analyze clinical data by allowing end-users to access multiple data sources simultaneously.
"It is a hybrid ETL and reporting and visualization tool that leverages the power of existing CDMS, EDC, and other clinical data systems," said Rick Morrison, CEO and Co-founder of Comprehend Systems, Inc. Live demonstrations in Booth 502 at DIA 2011 will showcase how Comprehend Clinical can facilitate real-time decision making for data managers, clinicians, clinical monitors, and executives.
Listen to Rick Morrison discuss analytics in clinicaltrials further here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
